Vol 9, No 3 (2013)

May/June

Open Access Open Access  Restricted Access Subscription or Fee Access

Table of Contents

Articles

Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States
Carl L. Roland, PharmD, Ashish V. Joshi, PhD, Jack Mardekian, PhD, Steven C. Walden, PharmD, MBA, James Harnett, PharmD, MS
PDF
161—175
Usefulness of the opioid risk tool to predict aberrant drug-related behavior in patients receiving opioids for the treatment of chronic pain
Lisa R. Witkin, MD, Dina Diskina, BS, Shawn Fernandes, BS, John T. Farrar, MD, PhD, Michael A. Ashburn, MD, MPH
PDF
177—187
Rationale and design of the Oxycodone Users Registry: A prospective, multicenter registry of patients with nonmalignant pain
Myoung Kim, PhD, Wing Chow, PharmD, MPH, Carmela Benson, MS
PDF
189—196
Gastrointestinal events after opioid treatment in nonmalignant pain: Correlates of occurrence and impact on health-related quality of life
Kate L. Lapane, PhD, Brian J. Quilliam, PhD, Carmela Benson, MS, Wing Chow, PharmD, MPH, Myoung S. Kim, PhD, MBA
PDF
205—216
Opioid prescribing knowledge and practices: Provider survey following promulgation of guidelines–Utah, 2011
Christina A. Porucznik, PhD, MSPH, Erin M. Johnson, MPH, Robert T. Rolfs, MD, MPH, Brian C. Sauer, PhD
PDF
217—224

Case Studies

Undetected Ultracet™ dependence in an adolescent with nonmalignant back pain
Nabil A. Khan, BA, Maria A. Sullivan, MD, PhD, Michael G. Vitale, MD, MPH, Mary Ellen Tresgallo, DNP, MPH, MS, John M. Saroyan, MD
PDF
225—230